熱門資訊> 正文
THC Therapeutics以1100万美元的全股交易收购大麻运营商THG
2025-06-24 20:48
- THC Therapeutics (OTC:THCT) acquired 100% of The Headquarters Group in an all-share deal valued at ~$11m.
- The transaction was completed through the issuance of 11.01M shares of newly created Series D Preferred stock.
- THG operates a portfolio of cannabis businesses spanning genetics, cultivation, extraction, distribution, nutrients, and specialty real estate.
- The acquired companies generate ~$4.8M in combined annual revenue.
- THCT and THG’s current operators will jointly manage the new combined entity.
- The acquisition provides THCT with a vertically integrated cannabis platform and supports its roll-up strategy. T
- THCT aims to expand acquired brands into additional U.S. states and international markets.
- Source: Press release
More on THC Therapeutics, Inc.
- Financial information for THC Therapeutics, Inc.
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。